Competition

  • September 15, 2026

    CMA Seeks Views On Outsourcer's £3.1B Deal For Mitie

    The antitrust watchdog said Tuesday that it is calling for responses on how the planned £3.1 billion ($4.2 billion) acquisition by outsourcing giant OCS of rival Mitie Group PLC could harm competition in Britain.

  • September 14, 2026

    Nektar 'Desperate' To Develop Rezpeg, Lilly Exec Tells Jury

    An Eli Lilly executive told a California federal jury on Monday in Nektar's $1 billion breach of contract suit against the pharma giant that his handwritten note from a meeting with Eli Lilly's CEO about Nektar being "desperate" was about the struggling company's need for its autoimmune-disease drug Rezpeg to succeed.

  • September 14, 2026

    Apple Urges High Court To Nix App Store Contempt Order

    Apple urged the U.S. Supreme Court on Monday to overturn a Ninth Circuit ruling that upheld a civil contempt order stemming from its decision to charge commissions to developers' transactions that steer users to cheaper outside payment methods to make purchases, saying it shouldn't be punished for violating the "spirit" of an injunction.

  • September 14, 2026

    Cumulus Tells 2nd Circ. Even Brief Stay Of Nielsen Order Is Bad

    Cumulus Media says it's going to be irreparably harmed if the Second Circuit doesn't lift the administrative stay it put in place stopping a preliminary injunction that Nielsen is challenging for the second time from going into effect while the appellate court looks at the matter.

  • September 14, 2026

    FTC's Meador Wants To Reassert Standalone Authority

    The Federal Trade Commission's Mark Meador on Monday sketched out an ambitious vision for the agency to use its unilateral authority to combat unfair methods of competition, despite rarely being invoked over the decades.

  • September 14, 2026

    Paramount Says Warner Bros. Deal Is Good For Competition

    Paramount has told a California federal court its planned $110 billion acquisition of Warner Bros. Discovery will be good for competition, arguing that challenges of the deal from state enforcers and the Writers Guild of America are misguided.

  • September 14, 2026

    SpaceXAI Drops Apple In Antitrust Claims For OpenAI Deal

    SpaceXAI on Monday dropped its claims that Apple breached antitrust laws by signing a deal with OpenAI to integrate ChatGPT into the iPhone but kept its claims against OpenAI Foundation intact.

  • September 14, 2026

    Jushi Opposes Pot Shop's Summary Bid On Antitrust Claims

    Cannabis giant Jushi Holdings and others are asking a federal court to toss a lawsuit alleging they made a $10 million deal to keep a rival out of town, arguing they did not participate in anticompetitive behavior and that the small, underfunded shop was never going to open regardless of anything they did.

  • September 14, 2026

    Eli Lilly's $200M Fraud Suit Is Still Defective, Church Cos. Say

    Companies affiliated with the Church of God in Christ urged a Florida federal judge to dismiss Eli Lilly's amended lawsuit alleging a $200 million-plus fraud scheme to resell the Trulicity diabetes drug on the secondary market, saying the latest complaint still lacks specificity despite including more claims. 

  • September 14, 2026

    FTC's View Of Construction Adhesives Market Won The Day

    A New York federal court found the Federal Trade Commission was right to focus on the retail market for various types of construction adhesives when asking to block Loctite-maker Henkel's planned $725 million acquisition of Liquid Nails, in an opinion made public Friday.

  • September 14, 2026

    Senators Draw Battle Lines Over Sweeping College Sports Bill

    U.S. senators on Monday made public statements on their positions either for or against a bill aimed at comprehensively regulating college sports, forecasting a bitter fight over the bill's passage in the upper chamber.

  • September 14, 2026

    Ex-Perrigo VP Escapes Some Price-Fixing Claims From AGs

    A Connecticut federal judge has tossed most of the claims against a former Perrigo executive in sprawling generic-drug price-fixing litigation brought by state enforcers, holding there is insufficient evidence he entered into antitrust conspiracies related to more than a dozen dermatological drugs, but teeing up a handful of other claims for trial.

  • September 14, 2026

    NCAA Asks 10th Circ. To Reverse Athlete Eligibility Ruling

    The NCAA has urged the Tenth Circuit to overturn a Colorado federal judge's ruling that could let thousands of college athletes who had exhausted their eligibility compete for another season, arguing the judge wrongly found they were likely to prove that excluding them from the league's newly expanded eligibility rules violates federal antitrust law.

  • September 14, 2026

    NextEra, Dominion Offer $1B Va. Plan Ahead Of $67B Merger

    NextEra Energy and Dominion Energy on Monday unveiled a benefits package aimed at winning support for their $67 billion proposed merger, including up to $1 billion in annual spending with Virginia suppliers for five years.

  • September 14, 2026

    NC Residents Lose Class Cert. Bid In Hospital Antitrust Fight

    A state court judge has denied class certification to a group of residents in western North Carolina in their healthcare antitrust case, saying they fell short of showing classwide impact in the form of allegedly increased premiums and decreased quality of care.

  • September 14, 2026

    DC Inks $9.3M Deals With 2 More Landlords In RealPage Case

    The District of Columbia has agreed to $9.3 million worth of settlements for its antitrust claims against two landlords it accused of using RealPage Inc.'s revenue management software for rent price-fixing, the city's attorney general announced Monday.

  • September 14, 2026

    Former DOJ Antitrust Leader Rejoins Winston Taylor

    The former deputy director of litigation for the U.S. Department of Justice's Antitrust Division, who was lead counsel for antitrust trials involving Live Nation-Ticketmaster and Google, has returned to Winston Taylor, the firm said Monday.

  • September 14, 2026

    Missing Agreement Sinks Conn. IT Firm's No-Poach Suit

    An information technology company failed to prove the existence of an oral agreement that a subcontractor would not pursue its clients, defeating its claims over the loss of a municipal contract with the town of Hamden, Connecticut, a state court judge ruled.

  • September 14, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week saw disputes over allegedly fabricated board approvals at a telecom infrastructure startup, insider trading and child safety at Roblox Corp. and ownership of artificial intelligence technology used in legal proceedings.

  • September 14, 2026

    Commerce Sets Early Duty Rate On Chinese Tin Mill Imports

    Chinese tin mill products entering the U.S. could face an over 66% countervailing duty after the U.S. Department of Commerce found in a preliminary determination that those products have been subsidized, according to a notice published Monday.

  • September 14, 2026

    Clippers Won't Take NBA To Court Over Salary Cap Sanctions

    Nearly two weeks after lawyers for the Los Angeles Clippers vowed to explore "every legal remedy" to challenge the NBA's sanctions against the franchise for violating salary cap rules, the team's owner has changed course and will comply with the league's decision.

  • September 11, 2026

    DOJ Gets Final OK For Agri Stats Antitrust Settlement

    A Minnesota federal court has granted final approval to the U.S. Department of Justice's settlement with Agri Stats, with the company agreeing to stop offering the sales reports for meat processors at the center of the case.

  • September 11, 2026

    Academic Publishers Tell 2nd Circ. Antitrust Case Fell Short

    Major publishers of academic journals urged the Second Circuit to reject an appeal from researchers accusing them of colluding to eliminate pay for peer reviewers and impose other restrictions, saying the case is based on ethical guidelines that do not reflect a conspiracy at all.

  • September 11, 2026

    Split Fed. Circ. Backs Amazon's Win Over Network Patent Suit

    A split Federal Circuit panel Friday upheld Amazon's escape from an infringement case over an AlterWAN Inc. network patent, with the dissenting judge saying the panel needlessly went "down the rabbit hole" and arrived at a "flat wrong" claim construction.

  • September 11, 2026

    Fed. Circ. Questions Medical Training Co.'s $100M Deal Theory

    A medical training startup urged the Federal Circuit on Friday to revive claims accusing Galderma of a "classic catch-and-kill strategy" to derail what it says could have been a $100 million deal with Allergan, but a three-judge panel questioned whether that theory had been properly presented below.

Expert Analysis

  • Why A Class Was Certified In Financial Aid Info-Sharing Case

    Author Photo

    The recent Illinois federal court decision in Corzo v. Brown University offers key guidance for defendants confronting class certification in antitrust matters, highlighting how typicality can be satisfied despite class members attending different universities, receiving different aid awards and being affected across different time periods, say attorneys at Baker McKenzie.

  • FTC Focus: Enforcing Vertically Integrated Operating Systems

    Author Photo

    As digital platforms increasingly pair operating systems with commerce, advertising, content and data, antitrust scrutiny will turn on whether those integrations create private bottlenecks that foreclose rivals through access, ranking, interoperability or defaults, pushing courts and enforcement agencies to adapt traditional utility and merger frameworks more aggressively, say attorneys at Proskauer.

  • China's New Outbound Investment Rule Reshapes Deal Risk

    Author Photo

    China's new outbound investment regulation introduces broad national security review and penalties, including personal liability, that will necessitate deeper diligence of cross-border deal participants with Chinese ties, earlier regulatory planning and closer attention to sanctions exposure, say attorneys at Freshfields.

  • A Shift In How Policymakers Are Approaching PBM Regulation

    Author Photo

    Recent federal and state legislative and regulatory activity involving pharmacy benefit managers represent a change in focus from transparency to PBM compensation structures, vertical integration and competitive effects, say attorneys at Barclay Damon.

  • How State Actions Are Reshaping Surveillance Pricing Risk

    Author Photo

    Amid heightened state enforcement activity and expanding legislative action to curb surveillance pricing concerns related to transparency, fairness and discrimination, businesses should closely examine how consumer data is used in pricing decisions, say attorneys at Steptoe.

  • Opinion

    States Should Reconsider Forced PBM Divestiture Laws

    Author Photo

    State legislatures are attempting to enact policies intended to force pharmacy benefit managers to divest from pharmacies, but these laws would have the practical effect of reducing patient access and competition, potentially violating the U.S. Constitution in the process, says former Utah Attorney General John Swallow.

  • HSR Deals Proceed More Steadily Than Narratives Suggest

    Author Photo

    The most recent Hart-Scott-Rodino Act data show that transaction volume remained relatively stable, transaction values continued to increase and enforcement activity remained low, suggesting that enforcement rates have been relatively consistent across presidential administrations despite widely differing public rhetoric regarding merger enforcement, says Amanda Wait at Michael Best.

  • Series

    Teaching SEC Investigations Makes Me A Better Lawyer

    Author Photo

    Instructing a law school course on U.S. Securities and Exchange Commission investigations has made me a more thoughtful, deliberate practitioner because it requires me to continually reassess and challenge what I know about securities law enforcement, how I know it and how best to explain it, says David Chase at Miami Law.

  • Noncompete Laws Show States Focusing On Bans, Healthcare

    Author Photo

    The first half of 2026 confirms that state legislatures are driving the most consequential changes in noncompete law, including a few state bans and several healthcare-specific laws, making a one-size-fits-all approach increasingly untenable for multistate employers, say attorneys at Faegre Drinker.

  • And Now A Word From The Panel: MDL Judge Selection

    Author Photo

    To understand how the Judicial Panel on Multidistrict Litigation selects particular judges to preside over MDL proceedings, it helps to consider not only how much experience on the federal bench a judge has, but also whether they have specifically managed any prior MDLs, says Alan Rothman at Sidley Austin.

  • Assessing DOJ Antitrust's New, Faster Merger Review Option

    Author Photo

    The U.S. Justice Department Antitrust Division's recently announced targeted second request option and new model timing signal a commercially friendly stance and a departure from the prior administration's position, say attorneys at Paul Weiss.

  • Series

    Judges On AI: Examining Administrative, Organizational Uses

    Author Photo

    U.S. District Judge Alan Albright of the Western District of Texas examines how artificial intelligence could transform a court's ability to deal with administrative work and organize materials when preparing for hearings or drafting opinions, thereby affording judges more time to resolve contested issues.

  • AG Watch: Ohio AG Joins State Antitrust Enforcement Trend

    Author Photo

    Amid the recent reprioritization in the federal government's competition enforcement agenda, two recent cases provide critical insight into how the Ohio attorney general will proceed in the relatively unprecedented trend of state attorneys general aggressively pursuing antitrust matters, say attorneys at BakerHostetler.

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • The Growing Antitrust Risks Of AI Pricing For Health Insurers

    Author Photo

    Attorneys at Patterson Belknap provide an overview of the increased risk of antitrust enforcement for health insurance companies using algorithmic price models, including in the form of multidistrict private litigation, new state and federal bills, and potential federal enforcement.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.